Guidelines for diagnosing steroid 21-hydroxylase deficiency

Clinical Pediatric Endocrinology

Volumn 8, Issue 1, 1999, Pages 57-60

  Saisho, Sumitaka ^a   Yokota, Ichiro ^b   Kusuda, Satoshi ^c   Tachibana, Katsuhiko ^d   Igarashi, Yoshio ^e   Suwa, Seizo ^d   Umehashi, Toyozo ^f   Fukushi, Masaru ^g   Fujieda, Kenji ^h  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c OSAKA CITY GENERAL HOSPITAL   (Japan)

^d Kanagawa Chidren's Medical Center   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Chemo Sero Therapeutic Research Institute   (Japan)

^g Sapporo City Institute of Public Health   (Japan)

^h HOKKAIDO UNIVERSITY   (Japan)

Author keywords

21 hydroxylase deficiency; Diagnosis; Neonatal screening

Indexed keywords

STEROID 21 MONOOXYGENASE;

ARTICLE; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; HUMAN; LABORATORY TEST; MOLECULAR DYNAMICS; NEWBORN SCREENING; PRACTICE GUIDELINE; STEROID 21 MONOOXYGENASE DEFICIENCY;

EID: 10344234404     PISSN: 09185739     EISSN: None     Source Type: Journal    
DOI: 10.1297/cpe.8.57     Document Type: Article

References (2)

1. Suwa S, Kusuda S, Toyoura T, Fujieda K, et al. Follow-up study of seventy cases with 21-hydroxylase deficiency detected in neonatal period. The Journal of the Japan Pediatric Society 1997; 101: 1149-57
2. Saisho S, Onishi T, Kashimada K, Koyama S, et al. Diagnostic procedures for the asymptomatic neonates referred from mass screening program for 21-hydroxylase deficiency. The Journal of the Japan Pediatric Society 1999; 103: 408-14